China · Delayed Price · Currency is CNY Cowealth Medical China Statistics
Total Valuation
SHA:603122 has a market cap or net worth of CNY 7.91 billion. The enterprise value is 7.82 billion.
| Market Cap | 7.91B |
| Enterprise Value | 7.82B |
Important Dates
The last earnings date was Saturday, March 14, 2026.
| Earnings Date | Mar 14, 2026 |
| Ex-Dividend Date | Jul 14, 2025 |
Share Statistics
SHA:603122 has 398.05 million shares outstanding. The number of shares has increased by 6.79% in one year.
| Current Share Class | 398.05M |
| Shares Outstanding | 398.05M |
| Shares Change (YoY) | +6.79% |
| Shares Change (QoQ) | -12.14% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | 1.12% |
| Float | 172.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.67 |
| PB Ratio | 7.46 |
| P/TBV Ratio | 7.53 |
| P/FCF Ratio | 2,276.48 |
| P/OCF Ratio | 447.36 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -232.53 |
| EV / Sales | 11.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2,251.61 |
Financial Position
The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.06 |
| Quick Ratio | 2.36 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | 17.64 |
| Interest Coverage | -17.83 |
Financial Efficiency
Return on equity (ROE) is -3.02% and return on invested capital (ROIC) is -4.32%.
| Return on Equity (ROE) | -3.02% |
| Return on Assets (ROA) | -1.77% |
| Return on Invested Capital (ROIC) | -4.32% |
| Return on Capital Employed (ROCE) | -3.89% |
| Weighted Average Cost of Capital (WACC) | 4.32% |
| Revenue Per Employee | 3.34M |
| Profits Per Employee | -165,729 |
| Employee Count | 203 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 3.11 |
Taxes
| Income Tax | -6.43M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +200.86% in the last 52 weeks. The beta is 0.01, so SHA:603122's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | +200.86% |
| 50-Day Moving Average | 17.22 |
| 200-Day Moving Average | 13.46 |
| Relative Strength Index (RSI) | 71.69 |
| Average Volume (20 Days) | 35,627,539 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603122 had revenue of CNY 677.79 million and -33.64 million in losses. Loss per share was -0.08.
| Revenue | 677.79M |
| Gross Profit | 94.77M |
| Operating Income | -41.30M |
| Pretax Income | -40.12M |
| Net Income | -33.64M |
| EBITDA | -33.81M |
| EBIT | -41.30M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 149.44 million in cash and 61.29 million in debt, with a net cash position of 88.16 million or 0.22 per share.
| Cash & Cash Equivalents | 149.44M |
| Total Debt | 61.29M |
| Net Cash | 88.16M |
| Net Cash Per Share | 0.22 |
| Equity (Book Value) | 1.06B |
| Book Value Per Share | 2.66 |
| Working Capital | 757.41M |
Cash Flow
In the last 12 months, operating cash flow was 17.68 million and capital expenditures -14.21 million, giving a free cash flow of 3.47 million.
| Operating Cash Flow | 17.68M |
| Capital Expenditures | -14.21M |
| Depreciation & Amortization | 7.49M |
| Net Borrowing | 10.81M |
| Free Cash Flow | 3.47M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 13.98%, with operating and profit margins of -6.09% and -4.96%.
| Gross Margin | 13.98% |
| Operating Margin | -6.09% |
| Pretax Margin | -5.92% |
| Profit Margin | -4.96% |
| EBITDA Margin | -4.99% |
| EBIT Margin | -6.09% |
| FCF Margin | 0.51% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.62%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 0.62% |
| Dividend Growth (YoY) | 116.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -6.79% |
| Shareholder Yield | -6.14% |
| Earnings Yield | -0.43% |
| FCF Yield | 0.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603122 has an Altman Z-Score of 7.34 and a Piotroski F-Score of 2.
| Altman Z-Score | 7.34 |
| Piotroski F-Score | 2 |